Sammour H, et al. - The effect of alpha lipoic acid (ALA) on uterine wound healing after primary cesarean section (CS) was investigated via performing a parallel-group, triple-blind, placebo-controlled randomized clinical trial in Ain Shams University Maternity Hospital, Cairo, Egypt, involving 102 women undergoing pre-labor primary CS. Participants were randomly assigned to receive oral ALA or a placebo twice daily for 6 weeks after CS, in a 1:1 ratio by an independent statistician (not involved in the treatment or data collection). The administration of ALA for 6 weeks postpartum led to improvement in uterine healing and a decrease in the incidence of scar niche among women undergoing primary CS.